• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    5.98 Down 0.25(4.01%) Jul 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:6.23
    Open:6.30
    Bid:N/A
    Ask:6.02 x 400
    1y Target Est:13.93
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:5.95 - 6.32
    52wk Range:3.80 - 8.16
    Volume:136,032
    Avg Vol (3m):332,348
    Market Cap:235.35M
    P/E (ttm):N/A
    EPS (ttm):-1.75
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TRVN

    Comparison

    Symbol% ChgMkt Cap
    TRVNDown 4.01%235.35M
    CYTKDown 4.59%273.34M
    NVSUp 0.88%250.43B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):392.30
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.50
    Quarterly EPS Est (Jun-15) :-0.37
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback